v3.26.1
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Oct. 20, 2025
Sep. 03, 2025
Jul. 19, 2024
May 29, 2024
Mar. 31, 2023
Jul. 13, 2022
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Jan. 01, 2026
Dec. 30, 2025
Feb. 10, 2025
Product Information [Line Items]                                  
Cash and cash equivalents             $ 25,233,369   $ 51,018,657 $ 104,164,128   $ 25,233,369 $ 104,164,128 $ 51,018,657      
Working Capital             47,463,865         47,463,865          
Net loss             15,820,277 $ 14,763,131   11,155,246 $ 9,405,315 30,583,408 20,560,561        
Assets             186,816,249   217,103,012 408,263,751   186,816,249 408,263,751 217,103,012      
Liabilities             91,035,190   91,231,675     91,035,190   91,231,675      
Noncontrolling interests             23,273,499   18,140,502     23,273,499   18,140,502      
Cumulative translation adjustments             (23,730)     927,462   (91,246) 1,423,000        
Cash balances             1,335,238   $ 1,788,119     1,335,238   $ 1,788,119      
Sales and maturities of marketable securities             25,930,902     9,323,535   41,430,736 9,323,535        
Net realized gain             168     435   7,280 435        
Contingent consideration, current                               $ 2,740,000  
Loss on change in fair value of contingent consideration             $ 0     0   2,760,000 0        
Payment for contingent consideration                       $ 0 265,538        
Common stock, par value (in dollars per share)             $ 0.0001   $ 0.0001     $ 0.0001   $ 0.0001      
Impairment of intangible assets, finite-lived                       $ 0   $ 8,020,343      
Impairment of intangible assets                 $ 22,627,902         30,648,245      
Impairment losses on equity investments without readily determinable fair value                 5,000,000         5,000,000      
Accounts receivable, allowance             $ 8,540,616   8,299,053     8,540,616   8,299,053 $ 8,299,053    
Additional provision for credit losses             1,106,983         2,834,253          
Accounts receivable, allowance for credit loss, writeoff             (1,070,126)         $ (2,592,690)          
Lease term (in years)                       10 years          
Maximum                                  
Product Information [Line Items]                                  
Sublease term (in years)                       3 years          
Rapid Temps Reporting Unit                                  
Product Information [Line Items]                                  
Goodwill, impairment loss                           8,718,398      
Several Reporting Units                                  
Product Information [Line Items]                                  
Goodwill, impairment loss                           49,509,698      
Exceptional Medical Transportation LLC                                  
Product Information [Line Items]                                  
Contingent consideration, current           $ 2,000,000 0   0     $ 0   0      
Contingent consideration period           2 years                      
Loss on change in fair value of contingent consideration             0     0   0 0        
Payment for contingent consideration                         265,538        
Voting interest           100.00%                      
PCA                                  
Product Information [Line Items]                                  
Contingent consideration, current         $ 15,822,190   5,076,592   5,076,592     5,076,592   5,076,592      
Contingent consideration period         36 months                        
Loss on change in fair value of contingent consideration             0     0   0 0        
Payment for contingent consideration       $ 1,000,000                          
Contingent consideration period to purchase remaining voting interest         49.00%                        
Business acquisition, equity interest issued     $ 1,814,345                            
Common stock, par value (in dollars per share)     $ 0.0001                            
Business acquisition, equity interest issued (in shares)     578,350                            
Voting interest   16.30%     51.00%                        
PCA | True-Up Payment                                  
Product Information [Line Items]                                  
Contingent consideration, current         $ 2,088,243                        
PCA | Earn Out Payment                                  
Product Information [Line Items]                                  
Contingent consideration, current         $ 13,733,947                        
Loss on change in fair value of contingent consideration   $ 196,488                              
Payment for contingent consideration   $ 1,687,134                              
Professional Technicians, LLC                                  
Product Information [Line Items]                                  
Contingent consideration, current             300,000   240,000     300,000   240,000     $ 240,000
Loss on change in fair value of contingent consideration             0     0   60,000 0        
Voting interest                                 100.00%
SteadyMD                                  
Product Information [Line Items]                                  
Contingent consideration, current $ 2,300,000           5,000,000   2,300,000     5,000,000   2,300,000      
Contingent consideration period 12 months                                
Loss on change in fair value of contingent consideration             0     0   2,700,000 0        
Voting interest 100.00%                                
PCA                                  
Product Information [Line Items]                                  
Contingent consideration, current             0   200,000     0   $ 200,000   $ 200,000  
Loss on change in fair value of contingent consideration             $ 0     $ 0   $ 0 $ 0        
Voting interest                               100.00%  
Cost of Goods and Service, Product and Service Benchmark | Supplier Concentration Risk | Vendor One                                  
Product Information [Line Items]                                  
Concentration risk                   13.00%     16.00%        
Customer One | Revenue Benchmark | Customer Concentration Risk                                  
Product Information [Line Items]                                  
Concentration risk             13.00%     34.00%   11.00% 42.00%        
Customer One | Accounts Receivable | Customer Concentration Risk                                  
Product Information [Line Items]                                  
Concentration risk                       16.00%   23.00%      
Customer Two | Revenue Benchmark | Customer Concentration Risk                                  
Product Information [Line Items]                                  
Concentration risk             11.00%         10.00%          
Customer Two | Accounts Receivable | Customer Concentration Risk                                  
Product Information [Line Items]                                  
Concentration risk                       14.00%   12.00%      
Variable Interest Entity, Not Primary Beneficiary                                  
Product Information [Line Items]                                  
Net loss             $ 2,292,093     $ 2,392,937   $ 4,059,850 $ 4,104,448        
Assets             8,719,363   7,039,301     8,719,363   $ 7,039,301      
Liabilities             23,522,309   17,782,198     23,522,309   17,782,198      
Noncontrolling interests             $ 14,802,946   $ 10,742,897     $ 14,802,946   $ 10,742,897